Financial Gravity Companies’s Gilead Sciences GILD Stock Holding History

Financial Gravity Companies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$164K	Buy	+1,478	New	+$157K	0.03%	176
2024 Q4	$137K	Buy	1,478 +1,468	+14,680%	+$132K	0.03%	172
2024 Q3	$838	Buy	+10	New	+$763	﹤0.01%	557
2018 Q4	$334K	Buy	+4,770	New	+$333K	0.3%	49
2018 Q1	$375K	Buy	5,616 +1,732	+45%	+$138K	0.38%	43
2017 Q4	$326K	Buy	+3,884	New	+$295K	0.37%	42

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Gravity Companies's GILD Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in Gilead Sciences (GILD) in Q2 2025: 1,478 shares worth $164K. The stake represents 0.03% of the portfolio and ranks #176 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in GILD as recently as Q4 2024.

Financial Gravity Companies first reported a position in GILD in Q4 2017 and has held it in 6 quarters since. The position peaked at $375K in Q1 2018. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Financial Gravity Companies held 1,478 shares of Gilead Sciences worth $164K as of Q2 2025.
Gilead Sciences was a new Financial Gravity Companies position in Q2 2025.
Gilead Sciences made up 0.03% of Financial Gravity Companies's portfolio in Q2 2025, its #176 holding.
Financial Gravity Companies first reported a position in Gilead Sciences in Q4 2017 and has held it in 6 quarters since.
Financial Gravity Companies's Gilead Sciences position peaked at $375K in Q1 2018.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.